Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1

Journal of General Virology

Volumn 86, Issue 8, 2005, Pages 2221-2229

  Espert, Lucile ^a   Degols, Geneviève ^a   Lin, Yea Lih ^b   Vincent, Thierry ^c   Benkirane, Monsef ^b   Mechti, Nadir ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; EXONUCLEASE; PROTEIN ISG20; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; VIRUS INHIBITION; VIRUS REPLICATION;

APOPTOSIS; CELL LINE; COCULTURE TECHNIQUES; DOWN-REGULATION; ENZYME INDUCTION; EXONUCLEASES; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; INTERFERONS; MUTATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 23044469969     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81074-0     Document Type: Article

References (70)

1. Baca, L. M., Genis, P., Kalvakolanu, D., Sen, G., Meltzer, M. S., Zhou, A., Silverman, R. & Gendelman, H. E. (1994). Regulation of interferon-α-inducible cellular genes in human immunodeficiency virus-infected monocytes. J Leukoc Biol 55, 299-309.
2. Barber, G. N. (2001). Host defence, viruses and apoptosis. Cell Death Differ 8, 113-126.
3. Benkirane, M., Neuveut, C., Chun, R. F., Smith, S. M., Samuel, C. E., Gatignol, A. & Jeang, K. T. (1997). Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 16, 611-624.
4. Bolt, G., Berg, K. & Blixenkrone-Moller, M. (2002). Measles virus-induced modulation of host-cell gene expression. J Gen Virol 83, 1157-1165.
5. Brand, S. R., Kobayashi, R. & Mathews, M. B. (1997). The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem 272, 8388-8395.
6. Cai, R., Carpick, B., Chun, R. F., Jeang, K. T. & Williams, B. R. (2000). HIV-1 TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 373, 361-367.
7. Chang, Y. E. & Laimins, L. A. (2001). Interferon-inducible genes are major targets of human papillomavirus type 31: insights from microarray analysis. Dis Markers 17, 139-142.
8. Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H. & Clavel, F. (1994). HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol 241, 651-662.
9. Cheung, C. Y., Poon, L. L., Lau, A. S., Luk, W., Lau, Y. L., Shortridge, K. F., Gordon, S., Guan, Y. & Peiris, J. S. (2002). Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837.
10. Clemens, M. J. & Elia, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17, 503-524.
11. Coccia, E. M., Krust, B. & Hovanessian, A. G. (1994). Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J Biol Chem 269, 23087-23094.
12. + T cells. Genome Res 11, 1198-1204.
13. D'Acquisto, F. & Ghosh, S. (2001). PACT and PKR: turning on NF-κB in the absence of virus. Sci STKE 2001, RE1.
14. Daher, A., Longuet, M., Dorin, D. & 9 other authors (2001). Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem 276, 33899-33905.
15. Demarchi, F., Gutierrez, M. I. & Giacca, M. (1999). Human immunodeficiency virus type 1 tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J Virol 73, 7080-7086.
16. de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Sllverman, R. H. & Williams, B. R. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69, 912-920.
17. Dhawan, S., Heredia, A., Wahl, L. M., Epstein, J. S., Meltzer, M. S. & Hewlett, I. K. (1995). Interferon-γ-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology 63, 93-99.
18. Espert, L., Degols, G., Gongora, C., Blondel, D., Williams, B. R., Sllverman, R. H. & Mechti, N. (2003a). ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 278, 16151-16158.
19. Espert, L., Gongora, C. & Mechti, N. (2003b). Interferon: antiviral mechanisms and viral escape (in French). Bull Cancer 90, 131-141.
20. Gale, M., Jr & Katze, M. G. (1998). Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78, 29-46.
21. Gatignol, A., Buckler-White, A., Berkhout, B. & Jeang, K. T. (1991). Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251, 1597-1600.
22. Gendelman, H. E., Baca, L., Turpin, J. A., Kalter, D. C., Hansen, B. D., Orenstein, J. M., Friedman, R. M. & Meltzer, M. S. (1990a). Restriction of HIV replication in infected T cells and monocytes by interferon-α. AIDS Res Hum Retroviruses 6, 1045-1049.
23. Gendelman, H. E., Baca, L. M., Turpin, J., Kalter, D. C., Hansen, B., Orenstein, J. M., Dieffenbach, C. W., Friedman, R. M. & Meltzer, M. S. (1990b). Regulation of HIV replication in infected monocytes by IFN-α. Mechanisms for viral restriction. J Immunol 145, 2669-2676.
24. Gil, J. & Esteban, M. (2000). Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5, 107-114.
25. Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A. & Mechti, N. (1997). Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem 272, 19457-19463.
26. Gongora, C., Degols, G., Espert, L., Hua, T. D. & Mechti, N. (2000). A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res 28, 2333-2341.
27. Gougeon, M. L. (2003). Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol 3, 392-404.
28. Gurer, C., Cimarelli, A. & Luban, J. (2002). Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J Virol 76, 4666-4670.
29. Hansen, B. D., Nara, P. L., Maheshwari, R. K., Sidhu, G. S., Bernbaum, J. G., Hoekzema, D., Meltzer, M. S. & Gendelman, H. E. (1992). Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120. J Virol 66, 7543-7548.
30. Honda, Y., Rogers, L., Nakata, K., Zhao, B. Y., Pine, R., Nakai, Y., Kurosu, K., Rom, W. N. & Welden, M. (1998). Type I interferon induces inhibitory 16-kD CCAAT/enhancer binding protein (C/ EBP)β, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 188, 1255-1265.
31. Huang, L. M., Joshi, A., Willey, R., Orenstein, J. & Jeang, K. T. (1994). Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J 13, 2886-2896.
32. Izmailova, E., Bertley, F. M., Huang, O., Makori, N., Miller, C. J., Young, R. A. & Aldovini, A. (2003). HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9, 191-197.
33. Karpov, A. V. (2001). Endogenous and exogenous interferons in HIV-infection. Eur J Med Res 6, 507-524.
34. Katze, M. G., He, Y. & Gale, M., Jr (2002). Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2, 675-687.
35. Korth, M. J. & Katze, M. G. (2002). Unlocking the mysteries of virus-host interactions: does functional genomics hold the key? Ann N Y Acad Sci 975, 160-168.
36. Kumar, M. & Carmichael, G. G. (1998). Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol Mol Biol Rev 62, 1415-1434.
37. Maitra, R. K. & Sllverman, R. H. (1998). Regulation of human immunodeficiency virus replication by 2′,5′-oligoadenylate-dependent RNase L. J Virol 72, 1146-1152.
38. Marin, M., Rose, K. M., Kozak, S. L. & Kabat, D. (2003). HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9, 1398-1403.
39. Martinand, C., Montavon, C., Salehzada, T., Sllhol, M., Lebleu, B. & Bisbal, C. (1999). RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73, 290-296.
40. Mattei, M. G., Tissot, C., Gongora, C. & Mechti, N. (1997). Assignment of ISG20 encoding a new interferon-induced PML nuclear body-associated protein, to chromosome 15q26 by in situ hybridization. Cytogenet Cell Genet 79, 286-287.
41. McMillan, N. A., Chun, R. F., Siderovski, D. P. & 7 other authors (1995). HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213, 413-424.
42. Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M. & Gabuzda, D. (2004). Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem 279, 7792-7798.
43. Meurs, E., Chong, K., Galabru, J., Thomas, N. S., Kerr, I. M., Williams, B. R. & Hovanessian, A. G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390.
44. Meurs, E. F., Watanabe, Y., Kadereit, S., Barber, G. N., Katze, M. G., Chong, K., Williams, B. R. & Hovanessian, A. G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 66, 5805-5814.
45. Meylan, P. R., Guatelli, J. C., Munis, J. R., Richman, D. D. & Kornbluth, R. S. (1993). Mechanisms for the inhibition of HIV replication by interferons-α, -β, and -γ in primary human macrophages. Virology 193, 138-148.
46. Muto, N. F., Martinand-Mari, C., Adelson, M. E. & Suhadolnik, R. J. (1999). Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct. J Virol 73, 9021-9028.
47. Nguyen, L. H., Espert, L., Mechti, N. & Wilson, D. M., III (2001). The human interferon and estrogen-regulated ISG20 /HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 40, 7174-7179.
48. Ott, D. E., Coren, L. V., Kane, B. P., Busch, L. K., Johnson, D. G., Sowder, R. C., II, Chertova, E. N., Arthur, L. O. & Henderson, L. E. (1996). Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J Virol 70, 7734-7743.
49. Ott, D. E., Coren, L. V., Johnson, D. G. & 7 other authors (2000). Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 266, 42-51.
50. Pantaleo, G. & Fauci, A. S. (1995). Apoptosis in HIV infection. Nat Med 1, 118-120.
51. Pitha, P. M. (1991). Multiple effects of interferon on HIV-1 replication. J Interferon Res 11, 313-318.
52. Pitha, P. M. (1994). Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Res 24, 205-219.
53. Player, M. R. & Torrence, P. F. (1998). The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol Ther 78, 55-113.
54. Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M. & Fauci, A. S. (1989). Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines. Science 244, 575-577.
55. Samuel, C. E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14, 778-809.
56. Selliah, N. & Finkel, T. H. (2001). Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Differ 8, 127-136.
57. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
58. Sheehy, A. M., Gaddis, N. C. & Malim, M. H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9, 1404-1407.
59. Shirazi, Y. & Pitha, P. M. (1992). Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J Virol 66, 1321-1328.
60. Shirazi, Y. & Pitha, P. M. (1993). Interferon α-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 193, 303-312.
61. Shirazi, Y. & Pitha, P. M. (1998). Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells. J Hum Virol 1, 69-76.
62. Simmen, K. A., Singh, J., Luukkonen, B. G., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R., Compton, T. & Fruh, K. (2001). Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A 98, 7140-7145.
63. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. (1998). How cells respond to interferons. Annu Rev Biochem 67, 227-264.
64. Tanaka, N., Sato, M., Lamphier, M. S., Nozawa, H., Oda, E., Noguchi, S., Schreiber, R. D., Tsujimoto, Y. & Taniguchi, T. (1998). Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3, 29-37.
65. +-T-cell lines. J Virol 77, 1392-1402.
66. Varela, N., Munoz-Pinedo, C., Ruiz-Ruiz, C., Robledo, G., Pedroso, M. & Lopez-Rivas, A. (2001). Interferon-γ sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism. J Biol Chem 276, 17779-17787.
67. Williams, B. R. (2001). Signal integration via PKR. Sci STKE 2001, RE2.
68. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P. & Yu, X. F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060.
69. Zhou, A., Hassel, B. A. & Silverman, R. H. (1993). Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72, 753-765.
70. Zimmerman, C., Klein, K. C., Kiser, P. K., Singh, A. R., Firestein, B. L., Riba, S. C. & Lingappa, J. R. (2002). Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 415, 88-92.